Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes - PubMed (original) (raw)
Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes
B Chesebro et al. J Virol. 1996 Dec.
Abstract
The V3 region of the human immunodeficiency virus type 1 (HIV-1) envelope protein is known to have a major influence on macrophage tropism as well as the ability to cause syncytium formation or fusion in CD4-positive lymphocyte cultures. Using infectious molecular HIV-1 clones, a series of mutant clones was created which allowed detailed mapping of V3 amino acid positions involved in these properties. In these experiments the non-syncytium-inducing phenotype in T cells did not always correlate with macrophage tropism. Macrophage tropism appeared to depend on the presence of certain combinations of amino acids at five specific positions within and just outside of the V3 loop itself, whereas syncytium formation in lymphocytes was influenced by substitution of particular residues at two to four positions within V3. In most cases, different V3 amino acid positions were found to independently influence macrophage tropism and syncytium formation in T cells and position 13 was the only V3 location which appeared to simultaneously influence both macrophage tropism and syncytium formation in lymphocytes.
Similar articles
- Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.
Ebenbichler C, Westervelt P, Carrillo A, Henkel T, Johnson D, Ratner L. Ebenbichler C, et al. AIDS. 1993 May;7(5):639-46. AIDS. 1993. PMID: 7686374 - Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1.
Mammano F, Salvatori F, Ometto L, Panozzo M, Chieco-Bianchi L, De Rossi A. Mammano F, et al. J Virol. 1995 Jan;69(1):82-92. doi: 10.1128/JVI.69.1.82-92.1995. J Virol. 1995. PMID: 7527089 Free PMC article. - A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection.
Musich T, Peters PJ, Duenas-Decamp MJ, Gonzalez-Perez MP, Robinson J, Zolla-Pazner S, Ball JK, Luzuriaga K, Clapham PR. Musich T, et al. J Virol. 2011 Mar;85(5):2397-405. doi: 10.1128/JVI.02187-10. Epub 2010 Dec 15. J Virol. 2011. PMID: 21159865 Free PMC article. - Pathogenesis of human immunodeficiency virus infection.
Levy JA. Levy JA. Microbiol Rev. 1993 Mar;57(1):183-289. doi: 10.1128/mr.57.1.183-289.1993. Microbiol Rev. 1993. PMID: 8464405 Free PMC article. Review.
Cited by
- Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages.
Sundaravaradan V, Das SR, Ramakrishnan R, Sehgal S, Gopalan S, Ahmad N, Jameel S. Sundaravaradan V, et al. Virol J. 2007 Nov 24;4:126. doi: 10.1186/1743-422X-4-126. Virol J. 2007. PMID: 18036244 Free PMC article. - Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.
Ping LH, Nelson JA, Hoffman IF, Schock J, Lamers SL, Goodman M, Vernazza P, Kazembe P, Maida M, Zimba D, Goodenow MM, Eron JJ Jr, Fiscus SA, Cohen MS, Swanstrom R. Ping LH, et al. J Virol. 1999 Aug;73(8):6271-81. doi: 10.1128/JVI.73.8.6271-6281.1999. J Virol. 1999. PMID: 10400718 Free PMC article. - Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration.
Ross HA, Rodrigo AG. Ross HA, et al. J Virol. 2002 Nov;76(22):11715-20. doi: 10.1128/jvi.76.22.11715-11720.2002. J Virol. 2002. PMID: 12388731 Free PMC article. - Virus and target cell evolution in human immunodeficiency virus type 1 infection.
Mosier DE. Mosier DE. Immunol Res. 2000;21(2-3):253-8. doi: 10.1385/IR:21:2-3:253. Immunol Res. 2000. PMID: 10852125 Review. - Mutational pathways and genetic barriers to CXCR4-mediated entry by human immunodeficiency virus type 1.
Huang W, Frantzell A, Toma J, Fransen S, Whitcomb JM, Stawiski E, Petropoulos CJ. Huang W, et al. Virology. 2011 Jan 20;409(2):308-18. doi: 10.1016/j.virol.2010.09.026. Epub 2010 Nov 10. Virology. 2011. PMID: 21071054 Free PMC article.
References
- Science. 1995 Jan 27;267(5197):483-9 - PubMed
- Virology. 1995 Jan 10;206(1):646-50 - PubMed
- J Virol. 1995 Mar;69(3):1755-61 - PubMed
- AIDS Res Hum Retroviruses. 1994 Dec;10(12):1679-84 - PubMed
- Curr Top Microbiol Immunol. 1995;202:89-104 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials